Semaglutide
The original blockbuster GLP-1 agonist — proven, affordable, and the gold standard starting point for weight loss.
Category
Weight Loss (GLP-1)
Frequency
Once weekly injection
Research
FDA Approved (Ozempic/Wegovy)What is Semaglutide?
Semaglutide is a GLP-1 receptor agonist developed by Novo Nordisk and sold under the brand names Ozempic (diabetes) and Wegovy (obesity). It was the drug that sparked the global weight loss peptide revolution and remains one of the most prescribed medications in the world.
The STEP clinical trials demonstrated an average weight reduction of 14.9% over 68 weeks at the 2.4mg dose. While this is less than Tirzepatide or Retatrutide, Semaglutide has the longest track record, the most real-world user data, and the most affordable research-grade price point.
For users new to GLP-1 peptides, or those seeking a reliable, well-understood option, Semaglutide remains an excellent first choice. It is also widely studied for cardiovascular benefits — the SUSTAIN trials showed a 26% reduction in major cardiovascular events.
How It Works
Semaglutide activates GLP-1 receptors in the hypothalamus (appetite regulation center of the brain), pancreas (insulin secretion), and gastrointestinal tract (gastric emptying and satiety signaling).
By mimicking the natural GLP-1 hormone (but with a much longer half-life — 7 days vs minutes for natural GLP-1), Semaglutide produces sustained appetite suppression, improved insulin sensitivity, and reduced fasting blood glucose.
The addition of a fatty acid chain to the molecule allows it to bind to albumin in the bloodstream, dramatically extending its half-life and enabling once-weekly dosing.
Benefits
- 14.9% average weight reduction in STEP trials (up to 17.4%)
- Proven cardiovascular benefits (26% reduction in major CV events)
- Extensive real-world safety data (7+ years)
- Affordable research-grade price vs Tirzepatide and Retatrutide
- Once-weekly dosing
- Improved blood sugar control
- Available in both injectable and oral forms
Dosing Protocol
| Phase | Dose | Frequency | Duration |
|---|---|---|---|
| Starting | 0.25mg | Once weekly | Weeks 1–4 |
| Titration 1 | 0.5mg | Once weekly | Weeks 5–8 |
| Titration 2 | 1mg | Once weekly | Weeks 9–16 |
| Titration 3 | 1.7mg | Once weekly | Weeks 17–20 |
| Maintenance | 2.4mg | Once weekly | Ongoing |
Always start at the lowest effective dose and titrate up gradually.
Side Effects
Common
- ⚠Nausea (very common in first 4–8 weeks)
- ⚠Diarrhea or constipation
- ⚠Vomiting (usually subsides after 2–4 weeks)
- ⚠Decreased appetite
- ⚠Burping or acid reflux
- ⚠Injection site redness or swelling
Rare
- •Pancreatitis
- •Diabetic retinopathy changes (in existing diabetics)
- •Gallstones or cholecystitis
- •Rapid heart rate
Who Should NOT Use Semaglutide
- ✕Personal or family history of medullary thyroid carcinoma (MTC)
- ✕Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
- ✕History of pancreatitis
- ✕Type 1 diabetes
- ✕Pregnancy or breastfeeding
- ✕Severe kidney or liver disease
What to Expect
Starting dose is sub-therapeutic — mainly for GI tolerance. Some mild nausea. Appetite slightly reduced.
Noticeable appetite reduction begins. Most users lose 2–4kg in this phase. Nausea may increase then settle.
Consistent weight loss at higher doses. Food cravings significantly reduced. The "food noise" effect is commonly reported.
Weight loss slows. Many users remain at 1mg or 1.7mg as maintenance. Some switch to Tirzepatide for additional results.
FAQ
Q: What is the difference between Ozempic and research Semaglutide?
A: The active molecule is identical. Ozempic is manufactured to pharmaceutical standards with strict quality controls and comes in a pre-filled pen. Research-grade Semaglutide is lyophilized powder that you reconstitute yourself. Quality varies heavily by supplier — always verify COA.
Q: Should I start with Semaglutide or Tirzepatide?
A: Semaglutide is a good starting choice if you want maximum safety data and the most affordable price. Tirzepatide produces ~50% more weight loss and has better GI tolerability. Both are excellent options.
Q: How long does reconstituted Semaglutide last?
A: Reconstituted Semaglutide stored in a refrigerator (2–8°C) is generally stable for 4–6 weeks. Always check your specific COA for storage recommendations.
Q: Can I use Semaglutide long-term?
A: Semaglutide is safe for long-term use based on clinical trial data of up to 4 years. Many users treat it as a maintenance medication indefinitely, similar to blood pressure medication.
Where to Get Semaglutide in Vietnam
See our community-verified supplier list with COA verification and cold-chain shipping to Vietnam.
View Supply Index